Medtronic gains cardiac-software clearances across two ablation platforms
Medtronic ($MDT) obtained FDA clearance and a European CE mark for its latest Affera Prism-2 cardiac mapping software, alongside a CE mark for the PulseSelect ProxBox adapter and Proximity Indicator software. The Affera upgrade adds tools for comparing electrical signals and marking pacing locations, while supporting three-dimensional visualization of diagnostic catheters during procedures for abnormal heart rhythms. The PulseSelect addition provides real-time, impedance-based information about